These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30529818)

  • 21. A comparative study of the antitumor efficacy of peptide-doxorubicin conjugates with different linkers.
    Liang Y; Li S; Wang X; Zhang Y; Sun Y; Wang Y; Wang X; He B; Dai W; Zhang H; Wang X; Zhang Q
    J Control Release; 2018 Apr; 275():129-141. PubMed ID: 29408580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel.
    Sun J; Chen Y; Li K; Huang Y; Fu X; Zhang X; Zhao W; Wei Y; Xu L; Zhang P; Venkataramanan R; Li S
    Acta Biomater; 2016 Oct; 43():282-291. PubMed ID: 27422196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effects of antitumor efficacy via mixed nano-size micelles of multifunctional Bletilla striata polysaccharide-based copolymer and D-α-tocopheryl polyethylene glycol succinate.
    Liu Y; Wu J; Huang L; Qiao J; Wang N; Yu D; Zhang G; Yu S; Guan Q
    Int J Biol Macromol; 2020 Jul; 154():499-510. PubMed ID: 32194114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route.
    Muley P; Kumar S; El Kourati F; Kesharwani SS; Tummala H
    Int J Pharm; 2016 Mar; 500(1-2):32-41. PubMed ID: 26792170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-delivery of Metformin and Paclitaxel Via Folate-Modified pH-Sensitive Micelles for Enhanced Anti-tumor Efficacy.
    Xiao Y; Wang S; Zong Q; Yin Z
    AAPS PharmSciTech; 2018 Jul; 19(5):2395-2406. PubMed ID: 29869309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
    Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
    Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
    Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
    Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox-Sensitive Micelles Based on O,N-Hydroxyethyl Chitosan-Octylamine Conjugates for Triggered Intracellular Delivery of Paclitaxel.
    Huo M; Liu Y; Wang L; Yin T; Qin C; Xiao Y; Yin L; Liu J; Zhou J
    Mol Pharm; 2016 Jun; 13(6):1750-62. PubMed ID: 27100204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy.
    Ma X; Özliseli E; Zhang Y; Pan G; Wang D; Zhang H
    Biomater Sci; 2019 Jan; 7(2):634-644. PubMed ID: 30534690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
    Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
    Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
    Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pH-sensitive polymeric micelles formed by doxorubicin conjugated prodrugs for co-delivery of doxorubicin and paclitaxel.
    Ma Y; Fan X; Li L
    Carbohydr Polym; 2016 Feb; 137():19-29. PubMed ID: 26686101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.
    Sun JJ; Chen YC; Huang YX; Zhao WC; Liu YH; Venkataramanan R; Lu BF; Li S
    Acta Pharmacol Sin; 2017 Jun; 38(6):823-834. PubMed ID: 28504251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 35. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.
    Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J
    Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
    Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
    Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance.
    Dong K; Yan Y; Wang P; Shi X; Zhang L; Wang K; Xing J; Dong Y
    Int J Nanomedicine; 2016; 11():5109-5123. PubMed ID: 27785018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles.
    Wang Y; Wang X; Deng F; Zheng N; Liang Y; Zhang H; He B; Dai W; Wang X; Zhang Q
    J Control Release; 2018 Jun; 279():136-146. PubMed ID: 29655991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W; Xi M; Duan X; Wang Y; Kong F
    Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.